How important is 24-hour continuous vs. episodic data capture?
53% - Very important
38% - Somewhat important
7% - Not important 2% - Episodic data is enoughWhat is driving RPM adoption? (choose all that apply)
72% - Patients’ reluctance to visit doctors/hospitals
34% - Need new revenue streams
27% – Expansion outside geographical area
1% - Other
What applications will use RPM? (choose all that apply)
55% - COVID-19 monitoring
50% - Chronic conditions monitoring
41% - Preventing rehospitalization
39% - Acute conditions monitoring
38% - Cardiac monitoring
12% - Chemotherapy monitoring
9% - Other
What stage level is your RPM adoption?
21% - Already used/adopted
16% - Plans to adopt within 6 months
8% - Plans to adopt within 6 to 12 months
22% - Considering; no plans yet
34% - No plans to adopt
Where will RPM adoption be in 5 years?
43% - On-par with in-patient monitoring
35% - Surpass in-patient monitoring
18% - Less than in-patient monitoring
3% - Other
1% - Usage limited
Source: VivaLNK
Explore the June 2021 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Zimmer Biomet to acquire Paragon 28
- Industrie 4.0 award for Paul Horn GmbH
- CMMC requirements and your business
- Stryker exiting spinal implant business
- Perfecting the manufacture of microscopically thin films for tech, medical applications
- Find out what 2025 holds for design and manufacturing
- Montagu to merge Tyber Medical, Intech and Resolve Surgical Technologies
- Americhem’s EcoLube MD PFAS-free internally lubricated compounds